Furthermore, previous studies proposed a correlation between upregulated TRAIL death receptor DR5 expression level and restored TRAIL sensitivity by several chemotherapeutic agents in HCC cells [15] or in leukemic cell lines [29]. Here, TNFSF10 is linked to hepatocellular carcinoma.